Pfizer Limited (NSE:PFIZER)
5,080.30
+101.40 (2.04%)
May 22, 2025, 3:30 PM IST
Pfizer Revenue
In the fiscal year ending March 31, 2025, Pfizer had annual revenue of 24.54B INR with 11.87% growth. Pfizer had revenue of 12.73B in the quarter ending March 31, 2025, with 132.88% growth.
Revenue
24.54B
Revenue Growth
+11.87%
P/S Ratio
9.28
Revenue / Employee
14.26M
Employees
1,721
Market Cap
227.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 24.54B | 2.60B | 11.87% |
Mar 31, 2024 | 21.93B | -2.32B | -9.55% |
Mar 31, 2023 | 24.25B | -1.86B | -7.13% |
Mar 31, 2022 | 26.11B | 3.71B | 16.54% |
Mar 31, 2021 | 22.40B | 887.20M | 4.12% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 271.45B |
Mankind Pharma | 127.44B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |